$GTLL This entire rebuilding process is challenging. The last two weeks brought that to a new level. We’ve completed our first full engagement with a new auditor and finalized our 10-K (12/30) and September 30 10-Q. While the conventional thought from the outside might assume that these are not linked, that's simply not the case. There were some unforeseen and unavoidable delays with the Q. The whole process required reconstructing 2+ years of historical records, contracts, and board actions—but our financial reporting cadence is now materially stronger.
Despite months of continuous coordination with auditors and regulators, timing constraints couldn’t be met. The 10-Q is being finalized today and, once filed, OTC Markets should lift our delinquent status on the next trading day. We realize this was not an ideal detour, but that's all that it really was, a detour. For some companies, a trading status issue becomes their identity. Not GTLL. Our journey remains unaffected, the business continues day to day and our goals remain intact.
Head down. Moving forward. More to come.
Transparency matters, and I’m doing my best to uphold that — so here’s where we are.
The audit process and 10-K review have been intense, and managing them while scaling three new divisions with a skeleton team has created delays. I own that.
As I said a month ago, fixing what was broken has been difficult. The main issue causing this holdup involves legacy equity exchange agreements from before my tenure. Getting these accounted for properly is critical for the future of our share structure — and everyone knows this has been one of our key long-term goals. That���s the reason for the delay. It couldn’t be helped, and everything else remains on schedule.
Monday’s call with our auditor was productive. He confirmed he now has sufficient documentation to complete the audit. He’ll be meeting with his PCAOB review board this week, and we expect updated timing feedback by Thursday, Dec 11.
We Appreciate the continued support from our $GTLL shareholders — we’re pushing through the last mile.
- Wyatt Flippen, CEO
$GTLL
When I first arrived, our focus was survival, undo bad deals and pick one business to build on. We chose the ultra high-growth Wellness market. With limited options, we started brokering pharma deals through 10Fold high volume, low-margin cashflow work that generated our first $1M+ in revenue early in the rebuild.
Since then, we’ve cleaned up the past and charged toward the future with PrimeCare Supply, PulseAi, and soon GlowWell Advisors. We now have 10 employees across the parent and two subsidiaries, plus 3 independent contractors working with us daily.
We’re developing AI-driven tools for direct-to-consumer wellness and clinic optimization, key drivers of our long-term growth.
Once our financials are published, the yield sign will come down and our OTCID application will move forward, updating everything that’s long overdue.
It’s a tough process to rebuild, but we’re getting stronger every day. More to come…
Wyatt Flippen, CEO
AI use in healthcare jumped from 25% to 70% since 2020. Data, precision, and automation are now essential. $GTLL #AIinHealthcare#HealthTech
Source: https://t.co/pzoK1yMxph
$GTLL Quick update as we close the week:
We don’t expect anything unusual with the audit. With a new PCAOB auditor, reviewing two years (FY24 & FY25) is standard, and we chose to take that full look-back to strengthen accuracy and transparency. Numbers are being finalized as we build a solid foundation for what’s next.
The more exciting part, our future.
After 11 months of fixing, planning, and executing, we’re now moving forward with clarity and momentum.
Our confidence in organic growth remains strong.
As noted in our Nov. 3 post, the global wellness economy is projected to hit $9.3T in two years, perfectly aligned with our operating divisions: Primecare Supply, GloWell Advisors, and PulseAi.
Two of the three are active, revenue-generating, and growing on schedule. More to come.
Have a great weekend.
Wyatt Flippen, CEO
#GTLL #HealthTech #Transparency #Growth
Our commitment 11 months ago was to do the hard work to rebuild the company for sustainable success. It took months to gain complete control of all the arms and legs.
This audit process is a painful but necessary step. We’re almost there. We are in balance sheet testing and reporting phase that ensures accuracy and transparency.
This is routine in rebuilding, but usually the SEC provides guidance for this. They are shut down so we’re dealing with it and pressing on. More to follow.
Wyatt Flippen, CEO $GTLL
“Growth requires structure. At GTLL, scalability begins with compliance and ends with innovation.” – H. Wyatt Flippen, CEO $GTLL #Leadership#CorporateGovernance
Good Afternoon. As I reported in 10/15, Our FY24 and FY25 audits remains in process. I know it’s frustrating but this is the last big hurdle between our past and our future.
Our team, new auditors, old auditors, CPA, 10Fold execs, and past leaders are all working daily to get our financials complete. In 11 months, I had to tear the company down to the bare chassis and rebuild it a piece at a time.
The auditor change was part of that rebuild. This is a huge, and painstaking step in that process that serves as the gateway to our future plans. More to come on that…
Wyatt Flippen, CEO $GTLL
The global wellness economy reached $6.3T and is expected to top $9T by 2028. Health, tech, and transparency are driving the new era of patient empowerment. $GTLL #WellnessEconomy#HealthTech
Source: https://t.co/8ITpaYZiHf
We listened, adapted, and built a stable model for the fast-growing wellness market.
Primecare now operates as a software + procurement agency with higher margins and control via our Sinq Ops system. Sales are climbing steadily. $GTLL
#GTLL#Primecare#HealthTech#Growth
Part 4: Catch up on our latest filings and updates:
8-K https://t.co/G02cCsoyTI
8-K https://t.co/esbJ7vIdP3
8-K https://t.co/gyFUQxk583
The FY25 10-K is coming soon — stay tuned here.
#GTLL#AuditUpdate
In Aug 2025, the SEC issued a comment letter that required us to terminate our prior auditor mid-stream.
We’ve engaged a new U.S.-based PCAOB auditor conducting a 2-year review (FY24 & FY25).
We’ve reached out to the SEC for guidance — but they’re currently closed.
Since Dec 2024, we’ve restructured operations, strengthened financial controls, and focused growth on our health-tech subsidiaries — Primecare Supply & GloWell Advisors.
Our FY25 audit is well underway.👇
Wyatt Flippen here — sending you my first post on X.
This is part of GTLL’s new communication initiative: full transparency, direct updates, and real engagement with our shareholders and supporters.
Here’s the latest on $GTLL 👇 📷
$GTLL @GlobalTechGTLL
New CEO has spent a lot of time and effort to reposition for success. 3 straight quarters of profits and reduced debt. He has cleaned up the meds of the past and will see .01+ soon and more. Best investment in OTC right now.